CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Nature Reviews Nephrology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41581-018-0001-yPMID 29654297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reproductive health and pregnancy in women with chronic kidney disease

  2018cited by this paper
• Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study

  2018cited by this paper
• The diabetes pandemic suggests unmet needs for ‘CKD with diabetes’ in addition to ‘diabetic nephropathy’—implications for pre-clinical research and drug testing

  2018cited by this paper
• Vascular endothelium in diabetes.

  2017cited by this paper
• Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes

  2017cited by this paper
• Accumulation of worn-out GBM material substantially contributes to mesangial matrix expansion in diabetic nephropathy.

  2017cited by this paper
• A more tubulocentric view of diabetic kidney disease

  2017cited by this paper
• Anti-TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy.

  2017cited by this paper
• Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function.

  2017cited by this paper
• Risk Factors for Severe Bleeding Complications in Percutaneous Renal Biopsy

  2017cited by this paper
• Targeting mTOR Signaling Can Prevent the Progression of FSGS.

  2017cited by this paper
• A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome.

  2017cited by this paper
• Differences in acute kidney injury ascertainment for clinical and preclinical studies

  2017cited by this paper
• Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction

  2017cited by this paper
• Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

  2017cited by this paper
• Kidney disease and obesity: epidemiology, mechanisms and treatment

  2017cited by this paper
• Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

  2017cited by this paper
• Microalbuminuria in Type-2 Diabetes Mellitus; the tip of iceberg of diabetic complications

  2017cited by this paper
• Liraglutide and Renal Outcomes in Type 2 Diabetes

  2017cited by this paper
• Single‐Nephron Glomerular Filtration Rate in Healthy Adults

  2017cited by this paper
• Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

  2017cited by this paper
• Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012

  2017cited by this paper
• Assessment of Global Kidney Health Care Status

  2017cited by this paper
• SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy

  2017cited by this paper
• MP393LONG-TERM SAFETY AND EFFECTIVENESS OF ECULIZUMAB FOR PATIENTS WITH ATYPICAL HAEMOLYTIC URAEMIC SYNDROME: OUTCOMES FROM A PROSPECTIVE OBSERVATIONAL CLINICAL TRIAL

  2017cited by this paper
• Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.

  2017cited by this paper
• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy.

  2017cited by this paper
• Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials.

  2017cited by this paper
• The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease.

  2017cited by this paper
• Predictors for the development of microalbuminuria and interaction with renal function

  2017cited by this paper
• US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.

  2017cited by this paper
• Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood

  2017cited by this paper
• Complications of Diabetes Diagnosed in Children and Adolescents-Reply.

  2017cited by this paper
• Chronic kidney disease

  2017cited by this paper
• Nondiabetic renal disease in patients with type 2 diabetes.

  2017cited by this paper
• Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies

  2016cited by this paper
• Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases

  2016cited by this paper
• Nephron Protection in Diabetic Kidney Disease.

  2016cited by this paper
• Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

  2016cited by this paper
• Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis

  2016cited by this paper
• Roles of mTOR complexes in the kidney: implications for renal disease and transplantation

  2016cited by this paper
• Innate immunity in diabetes and diabetic nephropathy

  2016cited by this paper
• Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy.

  2016cited by this paper
• C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria

  2016cited by this paper
• Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.

  2016cited by this paper
• Cardiac and Renovascular Complications in Type 2 Diabetes--Is There Hope?

  2016cited by this paper
• Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes.

  2016cited by this paper
• Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.

  2016cited by this paper
• Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis

  2016cited by this paper
• Hurdles to the introduction of new therapies for immune-mediated kidney diseases

  2016cited by this paper
• Predictive factors for non-diabetic nephropathy in diabetic patients. The utility of renal biopsy.

  2016cited by this paper
• CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes

  2016cited by this paper
• Targeting inflammation in diabetic kidney disease: early clinical trials

  2016cited by this paper
• The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial.

  2015cited by this paper
• US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

  2015cited by this paper
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

  2015cited by this paper
• Epidemiology of urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German T2DM patients.

  2015cited by this paper
• Epigenetic mechanisms in diabetic complications and metabolic memory

  2015cited by this paper
• Genetics of Diabetic Nephropathy: a Long Road of Discovery

  2015cited by this paper
• Urinary monocyte chemoattractant protein-1 and hepcidin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

  2015cited by this paper
• Nephrin Preserves Podocyte Viability and Glomerular Structure and Function in Adult Kidneys.

  2015cited by this paper
• Defective podocyte insulin signalling through p85-XBP1 promotes ATF6-dependent maladaptive ER-stress response in diabetic nephropathy

  2015cited by this paper
• Glomerular endothelial cell injury and cross talk in diabetic kidney disease.

  2015cited by this paper
• The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus.

  2015cited by this paper
• Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China中国糖尿病肾病研究现状：对中国国家自然科学基金数据的回顾性分析

  2015cited by this paper
• Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy

  2014cited by this paper
• Improved glycemic control and risk of ESRD in patients with type 1 diabetes and proteinuria.

  2014cited by this paper
• mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress

  2014cited by this paper
• Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions

  2014cited by this paper
• Is diabetic nephropathy reversible?

  2014cited by this paper
• Endothelial Dysfunction Plays a Key Role in Increasing Cardiovascular Risk in Type 2 Diabetes: The Hoorn Study

  2014cited by this paper
• [Medical significance of endothelial glycocalyx. Part 2: Its role in vascular diseases and in diabetic complications].

  2014cited by this paper
• Pattern recognition receptors and the inflammasome in kidney disease

  2014cited by this paper
• Changes in diabetes-related complications in the United States.

  2014cited by this paper
• Cystatin C– and Creatinine-Based Estimated Glomerular Filtration Rate, Vascular Disease, and Mortality in Persons With Diabetes in the U.S.

  2014cited by this paper
• Changes in diabetes-related complications in the United States, 1990-2010.

  2014cited by this paper
• Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

  2013cited by this paper
• miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes

  2013cited by this paper
• Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases

  2013cited by this paper
• The modern spectrum of renal biopsy findings in patients with diabetes.

  2013cited by this paper
• Diabetic nephropathy: Is it time yet for routine kidney biopsy?

  2013cited by this paper
• Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes

  2013cited by this paper
• Clinical implications of pathologic diagnosis and classification for diabetic nephropathy.

  2012cited by this paper
• Clinical Predictors of Non-diabetic Renal Disease and Role of Renal Biopsy in Diabetic Patients with Renal Involvement: A Single Centre Review

  2012cited by this paper
• Activated protein C ameliorates diabetic nephropathy by epigenetically inhibiting the redox enzyme p66Shc

  2012cited by this paper
• Podocyte Mitosis – A Catastrophe

  2012cited by this paper
• Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.

  2012cited by this paper
• Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

  2012cited by this paper
• Glomerular hyperfiltration: definitions, mechanisms and clinical implications

  2012cited by this paper
• Significance of renal biopsy in patients with presumed diabetic nephropathy

  2012cited by this paper
• Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS-/- db/db mice.

  2012cited by this paper
• Notice

  2012cited by this paper
• Non-diabetic renal disease in patients with type-2 diabetes mellitus.

  2012cited by this paper
• Identification of Cross-Species Shared Transcriptional Networks of Diabetic Nephropathy in Human and Mouse Glomeruli

  2012cited by this paper
• An orally active chemokine receptor CCR2 antagonist prevents glomerulosclerosis and renal failure in type 2 diabetes.

  2011cited by this paper
• Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes

  2011cited by this paper
• Clinical versus histological diagnosis of diabetic nephropathy--is renal biopsy required in type 2 diabetic patients with renal disease?

  2011cited by this paper
• Kidney biopsy in patients with diabetes mellitus.

  2011cited by this paper
• Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.

  2011cited by this paper
• Renal outcomes in patients with type 2 diabetes with or without coexisting non-diabetic renal disease.

  2011cited by this paper

• TangShenWeiNing formula alleviates diabetic kidney disease by inhibiting ferroptosis via AMPK pathway in renal tubular epithelial cells.

  2026cites this paper
• Elevated homocysteine contributes to the progression of type 1 diabetic nephropathy: Evidence from Mendelian randomization and experimental validation

  2026cites this paper
• Non-diabetic Kidney Disease in Type 2 Diabetes: From Kidney Biopsy to Precision Medicine

  2026cites this paper
• Multifactorial chronic kidney disease and the kidney capacity-workload balance.

  2026cites this paper
• Riboflavin intake and kidney health: population evidence and mechanistic insights from NHANES and molecular docking analyses

  2026cites this paper
• Development and validation of a multivariable prediction model for non-invasive discrimination between diabetic and non-diabetic kidney disease in type 2 diabetes: a clinical nomogram

  2026cites this paper
• Application of nanomaterials in the treatment of diabetes and its complications: As nanocarriers or with inherent therapeutic functions.

  2026cites this paper
• Microbiota-gut-kidney axis in health and renal disease

  2026cites this paper
• Association between malnutrition risk and diabetic nephropathy in adult patients with type 2 diabetes: a cross-sectional study and mediation analysis.

  2026cites this paper
• Can Variations in the Diet Quality Index Over Five Years Improve Renal Function and Lipid Profiles Among Patients with Type 2 Diabetes Mellitus? Results from the Prospective Azar Cohort Study

  2026cites this paper
• Biomedical applications of polysaccharide nanoparticles in kidney diseases: A review.

  2026cites this paper
• Ongoing and Novel Challenges in Kidney Transplantation: Therapeutic Approaches to Non-Immunological Risk Factors for Allograft Loss.

  2026cites this paper
• ZBP1 Mediates Renal Tubular Injury in Diabetic Nephropathy Through RIPK3-mediated Necroptosis

  2026cites this paper
• Risk stratification in diabetic kidney disease: a review of prediction models for methodological advances and clinical application.

  2026cites this paper
• Association of atherogenic index of plasma with cardiovascular disease mortality in patients with type 2 diabetes mellitus and diabetic kidney disease: a cross-sectional study

  2025cites this paper
• Herb-Drug Interactions Involving Pueraria Lobata and Its Bioactive Constituents: A Comprehensive Review

  2025cites this paper
• Time-Restricted Feeding Attenuates Kidney Damage and Preserves Renal Function in Mouse Model of Chronic Kidney Disease

  2025cites this paper
• The natural compound stachyose targets SGLT2-mediated metabolic reprogramming to ameliorate diabetic kidney disease.

  2025cites this paper
• Association between serum anion gap and all-cause mortality in critically ill patients with diabetic kidney disease: Analysis of the MIMIC-IV database

  2025cites this paper
• Research on podocyte injury mechanisms in diabetic nephropathy: a bibliometric and knowledge-map analysis from 2000 to 2024

  2025cites this paper
• XIAP-ULK1-mediated mitophagy modulates carnitine metabolism to mitigate diabetic kidney disease

  2025cites this paper
• Mogrosides Protect Against Diabetic Kidney Injury via Inhibiting Macrophage Activation in a Mouse Model

  2025cites this paper
• Advancing kidney protection in type 1 diabetes: insights from emerging therapies in type 2 diabetes and chronic kidney disease

  2025cites this paper
• Decreased Serum Adipose Triglyceride Lipase Level Is Associated With Renal Function Impairment in Patients With Type 2 Diabetes

  2025cites this paper
• Research Progress and Clinical Application of Drugs for Diabetic Kidney Disease

  2025cites this paper
• Trends, Social Determinants, and Lifestyle Factors Associated With Comorbidity of Diabetes and Kidney Diseases Among Chinese Adults Aged ≥ 45 Years

  2025cites this paper
• Nationwide Analysis of Progressive Kidney Function Decline and Diabetic Macular Edema in Type 2 Diabetes

  2025cites this paper
• An Enzyme‐Composite Sweat Sensor for the Detection of Multiplexed Diabetic Nephropathy Biomarkers

  2025cites this paper
• Relationship between bone turnover markers and diabetic kidney disease in patients with type 2 diabetes

  2025cites this paper
• Integrative transcriptomic and genomic insights into diabetic kidney disease: evidence from multi-omics analysis and experimental validation

  2025cites this paper
• Supplementation of Akkermansia muciniphila improves diabetic kidney disease by regulating gut microbiome in db/db mice

  2025cites this paper
• Loss of p300 in proximal tubular cells reduces renal fibrosis and endothelial-mesenchymal transition

  2025cites this paper
• Therapeutic effect of mesenchymal stem cells and their derived exosomes in diseases

  2025cites this paper
• Non-invasive biopsy diagnosis of diabetic kidney disease via deep learning applied to retinal images: a population-based study.

  2025influential citation
• Evaluating a pharmacist-led cardio-renal-metabolic service to reduce healthcare inequities in a socioeconomically deprived population: a prospective intervention study

  2025cites this paper
• A Multimodal Predictive Model for Chronic Kidney Disease and Its Association With Vascular Complications in Patients With Type 2 Diabetes: Model Development and Validation Study in South Korea and the U.K.

  2025cites this paper
• Ketone Bodies in Renal Function and Diabetic Kidney Disease.

  2025cites this paper
• Yishen Tongluo formula ameliorates kidney injury modulating inflammation and apoptosis in streptozotocin-induced diabetic kidney disease mice.

  2025cites this paper
• The impact of sex-related disparities on the association between triglyceride-glucose index and renal function decline in patients with type 2 diabetes: Insights from the ACCORD trial.

  2025cites this paper
• Huangkui capsules regulate tryptophan metabolism to improve diabetic nephropathy through the Keap1/Nrf2/HO-1 pathway

  2025cites this paper
• Explainable machine learning model incorporating social determinants of health to predict chronic kidney disease in type 2 diabetes patients

  2025cites this paper
• Association between Heart Rate Fragmentation and Kidney Function Decline in MESA: Evidence Consistent with Parasympathetic Degradation.

  2025cites this paper
• Global burden and epidemic trends of chronic kidney disease attributable to high body mass index: insights from the Global Burden of Disease Study 2021

  2025cites this paper
• Urine Biomarkers for Diabetic Kidney Disease Progression in Participants of the Chronic Renal Insufficiency Cohort Study.

  2025cites this paper
• Study on the modulation of kidney and liver function of rats with diabetic nephropathy by Huidouba through metabolomics.

  2025cites this paper
• Glomerular mesangial derived extracellular vesicles deteriorate diabetic kidney disease via miR-3147/PRKAR2B axis

  2025cites this paper
• The Effects of Different Types of Exercise on Pulmonary Inflammation and Fibrosis in Mice with Type 2 Diabetes Mellitus

  2025cites this paper
• Plasma complement proteins as biomarkers and therapeutic targets in chronic kidney disease: a Mendelian randomization analysis

  2025cites this paper
• Multi-omics characterization of diabetic nephropathy in the db/db mouse model of type 2 diabetes

  2025cites this paper
• Type 2 diabetes mellitus modifies the relationship between coronary artery calcification and adverse kidney outcome in patients with chronic kidney disease: the findings from KNOW-CKD

  2025cites this paper
• Alterations in serum exosomal miR-1207-5p levels reflect severity and progression risk in type 2 diabetic kidney disease

  2025cites this paper
• Association between Age of Onset of Hypertension and Risk of CKD

  2025cites this paper
• Small molecules targeting regulated cell death for chronic kidney disease therapy

  2025cites this paper
• Comparison of plasma p‐tau217/Aβ42, p‐tau217, and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease

  2025cites this paper
• Hypertension and BMI as Mediators of Type 2 Diabetes-Induced CKD: Insights from an Integrative Multi-Database Study

  2025cites this paper
• Mechanistic Insights into Myricetin-Regulated Autophagy via the PI3K/Akt and PINK1/Parkin Pathway in Diabetic Kidney Disease Treatment.

  2025cites this paper
• Modulation of Mesangial Cells by Tamsulosin and Pioglitazone Under Hyperglycemic Conditions: An In Vitro and In Vivo Study

  2025cites this paper
• Exploration of the renoprotective effect of Yi-Shen-Hua-Shi granules on db/db mice and the mechanism of podocyte apoptosis based on the GRP78/CHOP signaling pathway

  2025cites this paper
• Chronic Kidney Disease Among Diabetes Mellitus Patients in Southern Ethiopia: Burden, Awareness and Associated Factors - A Mixed Method Study

  2025cites this paper
• Finerenone: Evidence for Benefit in Early Stages of Cardiovascular-Kidney-Metabolic Syndrome

  2025influential citation
• Study on Predictive Models for Differential Diagnosis of Diabetic Kidney Disease and Non-Diabetic Kidney Disease Based on Clinical and Biochemical Indicators

  2025cites this paper
• Selected miRNAs in Urinary Extracellular Vesicles Show Promise for Early and Specific Diagnostics of Diabetic Kidney Disease

  2025cites this paper
• Increased SUMO-activating enzyme subunit 1 promotes glycolysis and fibrotic phenotype of diabetic nephropathy.

  2025cites this paper
• Finerenone Ameliorates High Glucose-Induced Podocytes Epithelial-Mesenchymal Transition Through the Regulation of Krüppel-Like Factor 5 in Diabetic Nephropathy

  2025cites this paper
• Application Value of A Clinical Radiomic Nomogram for Identifying Diabetic Nephropathy and Nondiabetic Renal Disease.

  2025cites this paper
• Novel Dual-Emissive Up-conversion Fluorescent Probe for Imaging Ectopic Lipid Accumulation in Diabetes Mellitus.

  2025cites this paper
• Identification of risk factors for renal progression in adults with IgAV: a retrospective cohort study of a single center in northwest China

  2025cites this paper
• Cardioprotective Effects of Dapagliflozin and Trimetazidine on Doxorubicin-Induced Cardiotoxicity in Streptozotocin-Induced Type 1 Diabetic Rats via Endoplasmic Reticulum Stress

  2025cites this paper
• Associations of MAFLD subtypes and air pollutants with multi-system morbidity and all-cause mortality: A prospective cohort study

  2025cites this paper
• Dapagliflozin effectiveness in improvement of clinical outcomes in diabetic patients (extention of CARDIA-MOS study, Moscow)

  2025cites this paper
• Proteome of Renal Tubuli and Serum Differentiate Pre‐Existing Type 2 Diabetes and Post‐Transplant Diabetes in Kidney Transplant Recipients

  2025cites this paper
• Quality indicators and clinical outcomes: the role of care quality in nondiabetic chronic kidney disease management

  2025cites this paper
• Role of zinc oxide nanoparticles supplementation on alleviate side effects of cisplatin induced cardiotoxicity in rats.

  2025cites this paper
• Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey (NHANES) 2003–2018

  2025cites this paper
• Effects of Holothuria leucospilota polysaccharide on alleviating diabetic kidney disease through regulating inflammation.

  2025cites this paper
• Effects of chronic kidney disease on complications and mortality after fracture surgery

  2025cites this paper
• Arg-Gly-Asp engineered mesenchymal stem cells as targeted nanotherapeutics against kidney fibrosis by modulating m6A.

  2025cites this paper
• Mesenchymal Stem Cells Restore Endothelial Integrity and Alleviate Emotional Impairments in a Diabetic Mouse Model via Inhibition of MMP-9 Activity

  2025cites this paper
• Emerging Biomarkers and Innovative Therapeutic Strategies in Diabetic Kidney Disease: A Pathway to Precision Medicine

  2025cites this paper
• The association between dietary live microbe intake and risk of chronic kidney disease among US adults: a cross-sectional survey from NHANES (2001–2018)

  2025cites this paper
• MRI-based habitat analysis of vascular and nerve invasion in the tumor microenvironment: an advanced approach for prostate cancer diagnosis

  2025cites this paper
• Dapagliflozin Attenuates Diabetes-Induced Podocyte Lipotoxicity via ERRα-Mediated Lipid Metabolism.

  2025cites this paper
• Genome-Wide Association Study of Quantitative Kidney Function in 52,531 Individuals with Diabetes Identifies Five Diabetes-Specific Loci.

  2025cites this paper
• Impact of HbA1c Reduction on Major Kidney Outcomes in Type 2 Diabetes With Poor Glycemic Control and Advanced CKD

  2025cites this paper
• Re: “Kidney Biopsy-Proven Diabetic and Non-Diabetic Kidney Diseases and Outcomes in Patients With Type 2 Diabetes Receiving Dialysis: The REIN Registry” by Ingwiller et al.

  2025cites this paper
• Natural products in treating diabetic kidney disease: a visualized bibliometric analysis

  2025cites this paper
• The association between single nucleotide polymorphisms in NLRP gene and diabetic nephropathy.

  2025cites this paper
• Tracing the molecular landscape of diabetic nephropathy: Insights from machine learning and experiment verification

  2025cites this paper
• Serum metabolic profiling in diabetic kidney disease patients using ultra-high performance liquid chromatography-tandem mass spectrometry

  2025cites this paper
• Detection of urinary SERPINA4 by electrochemiluminescence immunoassay and development of a diagnostic model for diabetic nephropathy

  2025cites this paper
• Approaches to predict future type 2 diabetes mellitus and chronic kidney disease: A scoping review

  2025cites this paper
• Construction of a PANoptosis-Related Gene Signature for Diabetic Nephropathy

  2025cites this paper
• Study the role of GLP-1 receptor agonist (Liraglutide) on experimentally induced diabetic nephropathy in male albino rats

  2025cites this paper
• Screening, prevalence, and burden of chronic kidney disease in people with type 2 diabetes managed by endocrinologists: A nationwide cross-sectional study.

  2025cites this paper
• Temporal multimorbidity patterns and cluster identification: a longitudinal analysis of administrative data

  2025cites this paper
• Multifactorial chronic kidney disease.

  2025cites this paper
• Identification of Shared Biomarkers in Chronic Kidney Disease and Diabetic Nephropathy Using Single-Cell Sequencing

  2025cites this paper
• Polygonati Rhizoma Polysaccharides Ameliorated Diabetic Kidney Disease in db/db Mice via Inhibiting TGFβ /Smad2 Signaling Pathway

  2025cites this paper
• Multimodal analysis stratifies genetic susceptibility and reveals the pathogenic mechanism of kidney injury in diabetic nephropathy

  2025cites this paper
• Ambient PM25 Plus High‐Fat Diet Exacerbated Kidney Injury in Mice by Activating Ferroptosis Mediated TGF‐β1/Smad2 Signaling Pathway

  2025cites this paper